Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
NextDecade
NEXT
$1.8B
| $1.82M | ﹤0.01% |
345,810
+154,244
| +81% | +$920K |
|
2977
Dave & Buster's
PLAY
$370M
| $1.82M | ﹤0.01% |
112,311
-56,488
| -33% | -$945K |
|
|
BULL
2978
PUT
Webull Corp
BULL
$4.23B
| $1.82M | ﹤0.01% |
234,200
-90,000
| -28% | -$905K |
|
2979
PUT
AutoNation
AN
$6.89B
| $1.82M | ﹤0.01% |
+8,800
| New | +$1.83M |
|
2980
Sasol
SSL
$7.17B
| $1.82M | ﹤0.01% |
+279,053
| New | +$1.76M |
|
2981
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $1.81M | ﹤0.01% |
4,000
| – | – |
|
|
CSR
2982
Centerspace
CSR
$939M
| $1.8M | ﹤0.01% |
26,968
+2,506
| +10% | +$157K |
|
2983
CALL
CDW
CDW
$17.8B
| $1.8M | ﹤0.01% |
+13,200
| New | +$1.95M |
|
2984
STAAR Surgical
STAA
$1.26B
| $1.8M | ﹤0.01% |
77,839
+6,666
| +9% | +$172K |
|
2985
First Advantage
FA
$3.81B
| $1.79M | ﹤0.01% |
123,523
+11,954
| +11% | +$168K |
|
2986
Shore Bancshares
SHBI
$799M
| $1.79M | ﹤0.01% |
101,211
+9,649
| +11% | +$162K |
|
2987
Gossamer Bio
GOSS
$83.3M
| $1.79M | ﹤0.01% |
576,533
+304,827
| +112% | +$870K |
|
2988
NETGEAR
NTGR
$647M
| $1.79M | ﹤0.01% |
72,774
+9,583
| +15% | +$276K |
|
|
ALM
2989
Almonty Industries
ALM
$4B
| $1.78M | ﹤0.01% |
201,934
+145,976
| +261% | +$1.07M |
|
2990
Absci
ABSI
$1.62B
| $1.78M | ﹤0.01% |
509,002
+273,622
| +116% | +$997K |
|
2991
CALL
AMC Entertainment Holdings
AMC
$2.35B
| $1.78M | ﹤0.01% |
1,138,700
| – | – |
|
|
JBGS
2992
JBG SMITH
JBGS
$692M
| $1.78M | ﹤0.01% |
104,381
+6,131
| +6% | +$116K |
|
2993
Worthington Steel
WS
$1.94B
| $1.77M | ﹤0.01% |
51,227
+4,208
| +9% | +$138K |
|
2994
Driven Brands
DRVN
$2.12B
| $1.77M | ﹤0.01% |
119,488
+7,692
| +7% | +$114K |
|
2995
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $1.77M | ﹤0.01% |
28,392
+3,431
| +14% | +$215K |
|
2996
TriMas Corp
TRS
$1.39B
| $1.77M | ﹤0.01% |
49,815
-3,982
| -7% | -$139K |
|
2997
Esquire Financial Holdings
ESQ
$1.59B
| $1.77M | ﹤0.01% |
17,295
+5,859
| +51% | +$594K |
|
2998
Enact Holdings
ACT
$6.84B
| $1.77M | ﹤0.01% |
44,526
+3,780
| +9% | +$142K |
|
|
UCTT
2999
Ultra Clean Holdings
UCTT
$4.21B
| $1.76M | ﹤0.01% |
69,655
+6,579
| +10% | +$175K |
|
3000
Equity Bancshares
EQBK
$1.07B
| $1.76M | ﹤0.01% |
39,427
+9,551
| +32% | +$409K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.